Answers are grounded in this paper and cite their sources.
We previously conducted longitudinal immunological studies in non‐cirrhotic chronic hepatitis C patients treated with direct‐acting antivirals (DAAs). However, whether cirrhosis alters these immunological dynamics remains unclear. We aimed to characterize regulatory T cells in HCV cirrhotic patients and evaluate their longitudinal changes during and following successful antiviral therapy in HCV cirrhotic patients. Fifty cirrhotic HCV genotype 4 patients and fifty age‐matched healthy controls were enrolled. Peripheral blood mononuclear cells were analysed at baseline, week 4, end of treatment, and 1 year post‐SVR using multicolour flow cytometry to quantify CD3 + , CD4 + , CD8 + , PD‐1 + , and CD38 + exhausted/activated CD8 + T cells, TH1, TH2, TH17 subsets, and CD4 + CD25 + FoxP3 + regulatory T cells (Tregs). Longitudinal changes were assessed using linear mixed‐effects models with FDR correction. At baseline, cirrhotic patients demonstrated marked immune dysregulation versus controls, with reduced CD3 + T cells, profound CD8 + T‐cell exhaustion (PD‐1 + 71.0% vs. 11.1%; p < 0.001), elevated CD38 + activation, depleted TH1 cells, and significant expansion of TH17 (25.8% vs. 14.0%; p < 0.001) and Tregs (52.7% vs. 15.1%; p < 0.001). Exhausted PD‐1 + CD8 + cells declined by 66.2% at 1 year ( q < 0.001), CD38 + CD8 + cells decreased by 31.3% ( q < 0.001), and Tregs normalized (52.7%–9.6%; q < 0.001). TH1 and TH2 subsets increased, TH17 declined, and total CD3 + /CD4 + T cells rose significantly by 1 year. In this single‐centre cohort of compensated genotype 4 HCV‐related cirrhosis, successful DAA therapy was associated with changes in circulating T‐cell phenotypes, including reductions in Tregs, TH17 cells, and PD‐1/CD38‐expressing CD8+ T cells. These findings suggest partial improvement in peripheral immune dysregulation after viral clearance, but require confirmation in larger multicentre studies with functional assays and longer follow‐up.
No takes yet. Share an insight, caveat, or question.
Soliman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: